182 related articles for article (PubMed ID: 28621229)
21. NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer.
Baird L; Yamamoto M
Mol Cell Biol; 2021 Jan; 41(2):. PubMed ID: 33139492
[TBL] [Abstract][Full Text] [Related]
22. The emerging role of the Nrf2-Keap1 signaling pathway in cancer.
Jaramillo MC; Zhang DD
Genes Dev; 2013 Oct; 27(20):2179-91. PubMed ID: 24142871
[TBL] [Abstract][Full Text] [Related]
23. Regulation and role of nuclear factor-E2-related factor 2 (Nrf2) in multidrug resistance of hepatocellular carcinoma.
Tian B; Lu ZN; Guo XL
Chem Biol Interact; 2018 Jan; 280():70-76. PubMed ID: 29223570
[TBL] [Abstract][Full Text] [Related]
24. Kelch-like ECH-associated Protein 1-dependent Nuclear Factor-E2-related Factor 2 Activation in Relation to Antioxidation Induced by Sevoflurane Preconditioning.
Cai M; Tong L; Dong B; Hou W; Shi L; Dong H
Anesthesiology; 2017 Mar; 126(3):507-521. PubMed ID: 28045693
[TBL] [Abstract][Full Text] [Related]
25. TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer.
Zhang B; Wu J; Cai Y; Luo M; Wang B; Gu Y
Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):375-385. PubMed ID: 30811526
[TBL] [Abstract][Full Text] [Related]
26. CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells.
Wang Q; Ma J; Lu Y; Zhang S; Huang J; Chen J; Bei JX; Yang K; Wu G; Huang K; Chen J; Xu S
Oncogene; 2017 Sep; 36(37):5321-5330. PubMed ID: 28534518
[TBL] [Abstract][Full Text] [Related]
27. Asiatic acid enhances Nrf2 signaling to protect HepG2 cells from oxidative damage through Akt and ERK activation.
Qi Z; Ci X; Huang J; Liu Q; Yu Q; Zhou J; Deng X
Biomed Pharmacother; 2017 Apr; 88():252-259. PubMed ID: 28110191
[TBL] [Abstract][Full Text] [Related]
28. The Dual Roles of NRF2 in Cancer.
Menegon S; Columbano A; Giordano S
Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
[TBL] [Abstract][Full Text] [Related]
29. Dietary cocoa protects against colitis-associated cancer by activating the Nrf2/Keap1 pathway.
Pandurangan AK; Saadatdoust Z; Esa NM; Hamzah H; Ismail A
Biofactors; 2015; 41(1):1-14. PubMed ID: 25545372
[TBL] [Abstract][Full Text] [Related]
30. The antioxidative potential of farrerol occurs via the activation of Nrf2 mediated HO-1 signaling in RAW 264.7 cells.
Ci X; Lv H; Wang L; Wang X; Peng L; Qin FX; Cheng G
Chem Biol Interact; 2015 Sep; 239():192-9. PubMed ID: 26111761
[TBL] [Abstract][Full Text] [Related]
31. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
Chen CS; Tseng YT; Hsu YY; Lo YC
Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038
[TBL] [Abstract][Full Text] [Related]
32. Bacillus amyloliquefaciens SC06 alleviates the oxidative stress of IPEC-1 via modulating Nrf2/Keap1 signaling pathway and decreasing ROS production.
Wang Y; Wu Y; Wang Y; Fu A; Gong L; Li W; Li Y
Appl Microbiol Biotechnol; 2017 Apr; 101(7):3015-3026. PubMed ID: 27957629
[TBL] [Abstract][Full Text] [Related]
33. Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs.
Wang XJ; Li Y; Luo L; Wang H; Chi Z; Xin A; Li X; Wu J; Tang X
Free Radic Biol Med; 2014 May; 70():68-77. PubMed ID: 24556415
[TBL] [Abstract][Full Text] [Related]
34. PF-4708671, a specific inhibitor of p70 ribosomal S6 kinase 1, activates Nrf2 by promoting p62-dependent autophagic degradation of Keap1.
Park JS; Kang DH; Lee DH; Bae SH
Biochem Biophys Res Commun; 2015 Oct; 466(3):499-504. PubMed ID: 26381178
[TBL] [Abstract][Full Text] [Related]
35. Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3.
Rojo AI; Medina-Campos ON; Rada P; Zúñiga-Toalá A; López-Gazcón A; Espada S; Pedraza-Chaverri J; Cuadrado A
Free Radic Biol Med; 2012 Jan; 52(2):473-87. PubMed ID: 22142471
[TBL] [Abstract][Full Text] [Related]
36. Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism.
Chartoumpekis DV; Wakabayashi N; Kensler TW
Biochem Soc Trans; 2015 Aug; 43(4):639-44. PubMed ID: 26551705
[TBL] [Abstract][Full Text] [Related]
37. DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1-Mediated NRF2 Ubiquitination.
Wang X; Zhou T; Yang X; Cao X; Jin G; Zhang P; Guo J; Rong K; Li B; Hu Y; Liu K; Ma P; Qin A; Zhao J
Adv Sci (Weinh); 2023 May; 10(14):e2204438. PubMed ID: 36965071
[TBL] [Abstract][Full Text] [Related]
38. An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses.
Lee S; Lim MJ; Kim MH; Yu CH; Yun YS; Ahn J; Song JY
Free Radic Biol Med; 2012 Aug; 53(4):807-16. PubMed ID: 22684019
[TBL] [Abstract][Full Text] [Related]
39. Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology.
Kim YJ; Ahn JY; Liang P; Ip C; Zhang Y; Park YM
Cancer Res; 2007 Jan; 67(2):546-54. PubMed ID: 17234762
[TBL] [Abstract][Full Text] [Related]
40. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
Shimozono R; Asaoka Y; Yoshizawa Y; Aoki T; Noda H; Yamada M; Kaino M; Mochizuki H
Mol Pharmacol; 2013 Jul; 84(1):62-70. PubMed ID: 23592516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
